Non-specific X-linked mental retardation;Retraso mental inespecífico ligado al cromosoma X

Revista de Neurologia

Volumn 42, Issue SUPPL.1, 2006, Pages

  Martínez Castellano, Francisco ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Chromatin; Genetic counselling; Learning; Mental retardation; Synapse; XLMR

Indexed keywords

ACYL COA SYNTHETASE LONG CHAIN FAMILY MEMBER 4 PROTEIN; ANGIOTENSIN 2 RECEPTOR; ARISTALESS RELATED HOMEOBOX PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN LIKE 1; JUMONJI AT RICH INTERACTIVE DOMAIN 1C PROTEIN; METHYL CPG BINDING PROTEIN 2; NEUROLIGIN; NEUROLIGIN 4; OLIGOPHRENIN 1; P21 ACTIVATED KINASE 3; POLYGLUTAMINE BINDING PROTEIN 1; POLYPEPTIDE; PROTEIN; PROTEIN ARHGEF 6; PROTEIN FGD 1; PROTEIN S6; PROTEIN XNP; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; S6 KINASE; SOLUTE CARRIER FAMILY 6 MEMBER 8 PROTEIN; TETRASPANIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 41; ZINC FINGER PROTEIN 81;

CHROMOSOME REARRANGEMENT; DENDRITE; FATTY ACID METABOLISM; GENE EXPRESSION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; HUMAN; MENTAL DEFICIENCY; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NON SPECIFIC X LINKED MENTAL RETARDATION; PROTEIN INTERACTION; REVIEW;

CHROMOSOME MAPPING; HUMANS; MENTAL RETARDATION, X-LINKED;

EID: 34548793461     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Penrose LS. A clinical and genetic study of 1280 cases of mental defect. Vol 229. London: HMSO; 1938.
2. Lehrke R. A theory of X-linkage of major intellectual traits. Am J Ment Defic 1972; 76: 611-9.
3. Stevenson RE, Schwartz CE, Schroer RJ. X-linked mental retardation. Oxford: Oxford University Press; 2000.
4. XLMR Genes Update Web Site. URL: http://xlmr.interfree.it/home.htm. Fecha última consulta: 10.2005.
5. Gecz J, Gedeon AK, Sutherland GR, Mulley JC. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet 1996; 13: 105-8.
6. Billuart P, Bienvenu T, Ronce N, Des Portes V, Vinet MC, Zemni R, et al. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998; 392: 923-6.
7. Zemni R, Bienvenu T, Vinet MC, Sefiani A, Carrie A, Billuart P, et al. A new gene involved in X-linked mental retardation identified by analysis of an X; 2 balanced translocation. Nat Genet 2000; 24: 167-70.
8. Kutsche K, Yntema H, Brandt A, Jantke I, Nothwang HG, Orth U, et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for rho GTPases, in patients with X-linked mental retardation. Nat Genet 2000; 26: 247-50.
9. Vervoort VS, Beachem MA, Edwards PS, Ladd S, Miller KE, De Mollerat X, et al. AGTR2 mutations in X-linked mental retardation. Science 2002; 296: 2401-3.
10. Shoichet SA, Hoffmann K, Menzel C, Trautmann U, Moser B, Hoeltzenbein M, et al. Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. Am J Hum Genet 2003; 73: 1341-54.
11. Kleefstra T, Yntema HG, Oudakker AR, Banning MJ, Kalscheuer VM, Chelly J, et al. Zinc finger 81 (ZNF81) mutations associated with X-linked mental retardation. J Med Genet 2004; 41: 394-9.
12. Carrie A, Jun L, Bienvenu T, Vinet MC, McDonell N, Couvert P, et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 1999; 23: 25-45.
13. D'Adamo P, Menegon A, Lo Nigro C, Grasso M, Gulisano M, Tamanini F, et al. Mutations in GDI1 are responsible for X-linked nonspecific mental retardation. Nat Genet 1998; 19: 134-9.
14. Allen KM, Gleeson JG, Bagrodia S, Partington MW, MacMillan JC, Cerione RA, et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 1998; 20: 25-30.
15. Salomons GS, Van Dooren SJ, Verhoeven NM, Marsden D, Schwartz C, Cecil KM, et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 2001; 68: 1497-500.
16. Stromme P, Mangelsdorf ME, Shaw MA, Lower KM, Lewis SM, Bruyere H, et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 2002; 30: 441-5.
17. Bienvenu T, Poirier K, Friocourt G, Bahi N, Beaumont D, Fauchereau F, et al. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X linked mental retardation. Hum Mol Genet 2002; 11: 981-91.
18. Meloni I, Muscettola M, Raynaud M, Longo I, Bruttini M, Moizard MP, et al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet 2002; 30: 436-40.
19. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP, et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004; 74: 552-7.
20. Ropers HH, Hoeltzenbein M, Kalscheuer V, Yntema H, Hamel B, Fryns JP, et al. Nonsyndromic X-linked mental retardation: where are the missing mutations? Trends Genet 2003; 19: 316-20.
21. Kalscheuer VM, Freude K, Musante L, Jensen LR, Yntema HG, Gecz J, et al. Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat Genet 2003; 35: 313-5.
22. Freude K, Hoffmann K, Jensen LR, Delatycki MB, Des Portes V, Moser B, et al. Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. Am J Hum Genet 2004; 75: 305-9.
23. Jensen LR, Amende M, Gurok U, Moser B, Gimmel V, Tzschach A, et al. Mutations in the JARID1C gene, encoding a protein involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am J Hum Genet 2005; 76: 227-36.
24. Tarpey P, Parnau J, Blow M, Woffendin H, Bignell G, Cox C, et al. Mutations in the DLG3 gene cause nonsyndromic X-Linked mental retardation. Am J Hum Genet 2004; 75: 318-24.
25. Frints SG, Borghgraef M, Froyen G, Marynen P, Fryns J P. Clinical study and haplotype analysis in two brothers with Partington syndrome. Am J Med Genet 2002; 112: 361-8.
26. Ropers HH, Hamel BC. X-linked mental retardation. Nat Rev Genet 2005; 6: 46-57.
27. Fischer M, Kaech S, Knutti D, Matus A. Rapid actin-based plasticity in dendritic spines. Neuron 1998; 20: 847-54.
28. Kim K, Hou P, Gorski JL, Cooper JA. Effect of Fgd1 on cortactin in Arp-2/3 complex-mediated actin assembly. Biochemistry 2004; 43: 2422-7.
29. Govek EE, Newey SE, Akerman CJ, Cross JR, Van der Veken L, Van Aelst L. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat Neurosci 2004; 7: 364-72.
30. Bagrodia S, Bailey D, Lenard Z, Hart M, Guan JL, Premont RT, et al. A tyrosine-phosphorylated protein that binds to an important regulatory region on the cool family of p21-activated kinase-binding proteins. J Biol Chem 1999; 274: 22393-400.
31. Ullrich O, Stenmark H, Alexandrov K, Huber LA, Kaibuchi K, Sasaki T, et al. Rab GDP dissociation inhibitor as a general regulator for the membrane association of rab proteins. J Biol Chem 1993; 268: 18143-50.
32. Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jacquot S, et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 1999; 285: 886-91.
33. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ III. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 2002; 16: 919-32.
34. Villard L, Fontes M. α-thalassemia/mental retardation syndrome, Xlinked (ATR-X, MIM #301040, ATRX/ XNP/XH2 gene MIM #300032). Eur J Hum Genet 2002; 10: 223-5.
35. Berube NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, Gibbons RJ, et al. The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest 2005; 115: 258-67.
36. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998; 393: 386-9.
37. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003; 302: 885-9.
38. Gecz J, Bielby S, Sutherland GR, Mulley JC. Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics 1997; 44: 201-13.
39. Tang AH, Neufeld TP, Rubin GM, Muller HA. Transcriptional regulation of cytoskeletal functions and segmentation by a novel maternal pair-rule gene, lilliputian. Development 2001; 128: 801-13.
40. Stipp CS, Hemler ME. Transmembrane-4-superfamily proteins CD151 and CD81 associate with alpha 3 beta 1 integrin, and selectively contribute to alpha 3 beta 1-dependent neurite outgrowth. J Cell Sci 2000; 113: 1871-82.
41. Okazawa H, Sudol M, Rich T. PQBP-1 (Np/PQ): a polyglutamine tract-binding and nuclear inclusion-forming protein. Brain Res Bull 2001; 56: 273-80.
42. Rapoport SI, Chang MC, Spector AA. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 2001; 42: 678-85.
43. Saavedra JM. Emerging features of brain angiotensin receptors. Regul Pept 1999; 85: 31-45.
44. Wang YE, Esbensen P, Bentley D. Arginine kinase expression and localization in growth cone migration. J Neurosci 1998; 18: 987-98.
45. Poirier K, Lacombe D, Gilbert-Dussardier B, Raynaud M, Desportes V, De Brouwer AP, et al. Screening of ARX in mental retardation families: consequences for the strategy of molecular diagnosis. Neurogenetics 2006 [in press].
46. Mandel JL, Chelly J. Monogenic X-linked mental retardation: is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations. Eur J Hum Genet 2004; 12: 689-93.